Gradiant Corporation
Financials
Valuation Metrics
Gradiant Corporation's Market Cap is ₩1352B. At end of 2025 it was ₩1275B. Ranked #1084 of 2,421 in KR market (top 45%), #560 of 1,640 on KOSDAQ (top 34%), #26 of 47 in Consumer Discretionary Distribution & Retail (top 55%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 135.21B KRW | KR#1,084/2,421 Sec#26/47 |
| Revenue | 3.43T KRW | KR#181/2,421 Sec#7/47 |
| Net Income | -2.01B KRW | KR—/2,421 Sec—/47 |
| Total Assets | 1.86T KRW | KR#314/2,421 Sec#10/47 |
| Net Assets | 724.62B KRW | KR#380/2,421 Sec#14/47 |
| Employees | 63 | KR#1,940/2,421 Sec#34/47 |
| Value | ||
| P/B | 0.19x | KR#106/2,421 Sec#5/47 |
| P/S | 0.04x | KR#14/2,421 Sec#1/47 |
| FCF Yield | -6.98% | KR—/2,421 Sec—/47 |
| Profitability | ||
| ROE | -0.28% | KR#1,565/2,421 Sec#29/47 |
| ROA | -0.11% | KR#1,559/2,421 Sec#29/47 |
| Op. Margin | -0.19% | KR#1,617/2,421 Sec#35/47 |
| Revenue Growth | 11.10% | KR#850/2,421 Sec#12/47 |
| Financial Health | ||
| Debt Ratio | 156.10% | KR#1,942/2,421 Sec#35/47 |
| Total Debt | 182.52B KRW | KR#540/2,421 Sec#18/47 |
| FCF | -9.44B KRW | KR#1,690/2,421 Sec#32/47 |
| Cash | 132.02B KRW | KR#382/2,421 Sec#8/47 |
| Current Ratio | 1.12x | KR#1,584/2,421 Sec#27/47 |
| Dividend | ||
| Div. Yield | 1.65% | KR#962/2,421 Sec#21/47 |
| Div. Growth | 0.00% | KR—/2,421 Sec—/47 |
| Performance | ||
| 1Y Return | -18.41% | KR#1,224/2,421 Sec#18/47 |
| 1M Return | 2.63% | KR#968/2,421 Sec#14/47 |
| From 52W High | -20.91% | KR#272/2,421 Sec#7/47 |
| 1Y MDD | -49.00% | KR#946/2,421 Sec#22/47 |
| Trading | ||
| Volume | 47,685 shares | KR#1,157/2,421 Sec#22/47 |
| Trading Value | 576.4M KRW | KR#892/2,421 Sec#11/47 |
| Foreign Own. | 3.23% | KR#1,221/2,421 Sec#25/47 |
| Per Share | ||
| EPS | -180 KRW | KR—/2,421 Sec—/47 |
| BPS | 64,848 KRW | KR#212/2,421 Sec#7/47 |
Company Info
Gradient, established in 1997 and listed on KOSDAQ in 1999, entered the healthcare industry in 2014 and completed the incorporation and absorption merger of subsidiaries in 2025. It provides comprehensive management for affiliated companies, B2B e-commerce for industrial goods, bio-healthcare business (including development, research, and distribution of pharmaceuticals and medical supplies), and integrated logistics agency services. Through its health functional food brand Radiewell and inner beauty brand Leanfit, the company focuses on selecting premium ingredients and developing products, pursuing global business expansion. Gradient is headquartered in Gangnam-gu, Seoul.